Cerner president Zane Burke to leave in November

Matt O'Connor | | Health Imaging | Enterprise Imaging
Zane Burke

Cerner announced Monday, Sept. 10, that its president, Zane Burke, will leave the company. The move is effective Nov. 2, according to a news release.

“We thank Zane for his contributions to Cerner across more than two decades,” said Cerner Chairman and CEO Brent Shafer, in a prepared statement. “Zane leaves the company with a strong client focus and commitment to continued innovation, partnership and sustainable growth deeply engrained in our culture and leadership philosophy. I am very confident in the capabilities of Cerner’s strong and experienced leadership team.”

Burke joined the health technology company in 1996 where he took on a number of executive positions until he was named president in 2013.

John Peterzalek, executive vice president of worldwide client relationships will assume Burke’s day-to-day tasks and the title of chief client officer. The role is effective immediately.

""
Matt O'Connor

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Related Content

'Ad hoc' shifts and radiology 'maestros': How one department addressed its workflow hiccups
Prompts matter: How input elements affect large language model performance
AI can help radiology standardize image exam data labeling
Imaging leaders share 7 key considerations for remote scanning programs
PHOTO GALLERY: Medical imaging technology at RSNA 2024
Can large language models break language barriers in radiology reports?

Around the web

Radiology Business
AI can help radiology standardize image exam data labeling

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.